Petrelintide
Obesity Or Overweight, Cardiovascular Disease
Phase III
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
Sep 22, 2026
―
Petrelintide
Obesity Or Overweight
Phase III
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Sep 11, 2026
―
Petrelintide
Type 2 Diabetes, Obesity Or Overweight
Phase III
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Sep 11, 2026
―
Zp6590, Solution For Injection
Healthy Participants Study, Overweight And Obese Adults, First In Man Study To Evaluate Initial Safety
Early Phase I
Recruiting
A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
Jul 16, 2026
Glepaglutide 10 Mg
Short Bowel Syndrome (Sbs)
Phase III
Active Not Recruiting
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Nov 13, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Zealand Pharma (22Z) have in its pipeline
22Z is currently developing the following drugs: Petrelintide, Petrelintide, Petrelintide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.